An Open-label, Single-arm, Rater-blinded, Multicenter Phase 1/2 Study to Assess Safety and Diagnostic Accuracy and Radiotherapeutic Implications of Pre-operative Ga-68-PSMA-11 PET/CT Imaging in Comparison to Histopathology, in Newly-diagnosed Prostate Cancer (PCA) Patients at High Risk for Metastasis, Scheduled for Radical Prostatectomy (RP) With Extended Pelvic Lymph Node Dissection (EPLND)
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions; Diagnostic use
- 24 Jul 2020 Status changed from recruiting to completed.
- 08 Apr 2020 This trial has been completed in Austria, as per European Clinical Trials Database record
- 03 Apr 2020 This trial has been completed in Germany as per European Clinical Trials Database record